← Back to Search

Treatment for Brain Tumor (iCaRe2 Trial)

N/A
Recruiting
Led By Ken Cowan, MD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 50 years
Awards & highlights

Summary

This trial is for collecting and managing standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls in order to study cancer development and progression and enable the design of strategies for prevention, screening, early detection and personalized treatment of cancer.

Eligible Conditions
  • Brain Tumor
  • Thyroid Cancer
  • Thymic Cancer
  • Colorectal Cancer
  • Cholangiocarcinoma
  • Stomach Cancer
  • Small Intestine Cancer
  • Peritoneal Malignancies
  • Adenomatous Polyposis
  • Kidney Cancer
  • Hypopharyngeal Cancer
  • Lip Cancer
  • Oropharyngeal Cancer
  • Skin Cancer
  • Mesothelioma
  • Breast Cancer
  • Melanoma
  • Multiple Myeloma
  • Ovarian Cancer
  • Endometrial Cancer
  • Neuroendocrine Tumors
  • Colon Cancer
  • Anal Cancer
  • Gallbladder Cancer
  • Penile Cancer
  • Nasopharyngeal Cancer
  • Prostate Cancer
  • Laryngeal Cancer
  • Oral Cancers
  • Unknown Primary Tumors
  • Liver Cancer
  • Pancreatic Cancer
  • Gastrointestinal Stromal Tumors
  • Nasal Cavity Cancer
  • Brain Cancer
  • Leukemia
  • Sarcoma
  • Vaginal Cancer
  • Esophageal Cancer
  • Testicular Cancer
  • Ureteral Cancer
  • Urethral Cancer
  • Duodenal Cancer
  • Lynch Syndrome
  • Bladder Cancer
  • Paranasal Sinus Cancer
  • Salivary Gland Cancer
  • Healthy Controls
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~50 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 50 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Development and implementation of a web-based Cancer Collaborative Registry at the University of Nebraska Medical Center (UNMC)/Nebraska Medical Center (NMC)
Secondary study objectives
Procurement and banking of excess biological material for future analysis
Other study objectives
Collection and banking of blood, DNA, and urine samples for future analysis that will be proposed in future studies

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
554 Previous Clinical Trials
145,437 Total Patients Enrolled
Ken Cowan, MDPrincipal InvestigatorUniversity of Nebraska
Whitney Goldner, MDPrincipal Investigator - University of Nebraska
University Of Nebraska College Of Medicine (Medical School)
University Iowa Hosps & Clinics (Residency)
2 Previous Clinical Trials
68 Total Patients Enrolled
~666666 spots leftby Dec 2099
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top